Carbidopa-Levodopa-Entacapone 50 (12.5mg-50mg-200mg)

Carbidopa-Levodopa-Entacapone 50 (12.5mg-50mg-200mg) – Comprehensive Product Overview

Carbidopa-Levodopa-Entacapone 50 is a prescription medication used in the management of Parkinson’s disease, particularly in patients who experience motor fluctuations and “wearing-off” symptoms during Levodopa therapy. Each tablet contains Carbidopa 12.5mg, Levodopa 50mg, and Entacapone 200mg, a combination designed to improve dopamine availability and prolong symptom control.

This triple-combination therapy helps increase the effectiveness of Levodopa while reducing fluctuations in movement control throughout the day. By combining three complementary medications into a single tablet, Carbidopa-Levodopa-Entacapone 50 offers a convenient treatment option for patients requiring optimized Parkinson’s disease management.

What Is Carbidopa-Levodopa-Entacapone 50 Used For?

Carbidopa-Levodopa-Entacapone 50 may be prescribed for:

• Parkinson’s disease
• Management of motor fluctuations
• Reduction of “wearing-off” episodes between doses
• Control of tremors and muscle rigidity
• Improvement of movement coordination
• Long-term dopamine replacement therapy
• Patients requiring prolonged Levodopa effectiveness

How Carbidopa-Levodopa-Entacapone 50 Works

Levodopa is converted into dopamine after reaching the brain, helping replenish the neurotransmitter that becomes deficient in Parkinson’s disease. This increased dopamine activity improves communication between nerve cells responsible for movement and coordination.

Carbidopa prevents the premature breakdown of Levodopa before it reaches the brain, allowing more active medication to become available where it is needed. Entacapone inhibits the COMT (Catechol-O-Methyltransferase) enzyme, slowing the breakdown of Levodopa and extending its therapeutic effects. Together, these three ingredients help provide more consistent symptom control.

Benefits of Carbidopa-Levodopa-Entacapone 50 Therapy

• Helps improve motor function and movement control
• May reduce “off” periods between medication doses
• Extends the effectiveness of Levodopa therapy
• Supports smoother daily activities
• Helps manage tremors and muscle stiffness
• Improves walking ability and balance
• Provides convenient triple-combination treatment

Dosage and Administration

Carbidopa-Levodopa-Entacapone 50 should always be taken exactly as prescribed by a qualified healthcare professional. The appropriate dosage depends on disease severity, previous Parkinson’s treatments, individual response, and overall health status.

The tablet should generally be swallowed whole with water and may be taken with or without food according to your physician’s instructions. Consistent dosing schedules help maintain stable symptom control throughout the day.

Do not alter the prescribed dose or discontinue treatment without consulting your healthcare provider, as abrupt withdrawal may lead to worsening symptoms or serious complications.

Possible Side Effects

Like all medications, Carbidopa-Levodopa-Entacapone 50 may cause side effects, although not everyone experiences them.

• Nausea
• Dizziness
• Drowsiness
• Headache
• Diarrhea
• Dry mouth
• Sleep disturbances
• Low blood pressure upon standing
• Involuntary movements (dyskinesia)
• Brownish-orange discoloration of urine

Seek immediate medical attention if severe reactions occur, including hallucinations, chest pain, severe allergic reactions, persistent diarrhea, confusion, or unusual behavioral changes.

Warnings and Precautions

• Use only under medical supervision.
• Inform your doctor about all prescription and non-prescription medications.
• Patients with liver disease may require additional monitoring.
• Use caution when driving or operating machinery.
• Do not discontinue treatment abruptly.
• Regular follow-up appointments may be necessary during therapy.

Storage Instructions

• Store at room temperature below 25°C.
• Protect from excessive heat, moisture, and direct sunlight.
• Keep the medication in its original packaging.
• Keep out of reach of children and pets.
• Do not use after the expiration date.

Related Resources

Learn more about Parkinson’s disease management and neurological health in our
Health Blog.

Need assistance regarding your medication order? Visit our
Contact Page.

For official medical information about Carbidopa, Levodopa, and Entacapone therapy, refer to the

MedlinePlus Levodopa, Carbidopa and Entacapone Drug Information
.

Frequently Asked Questions (FAQs)

1. What is Carbidopa-Levodopa-Entacapone 50 primarily prescribed for?

Carbidopa-Levodopa-Entacapone 50 is primarily prescribed for Parkinson’s disease patients who experience motor fluctuations or “wearing-off” symptoms while receiving Levodopa therapy.

2. Why does this medication contain Entacapone?

Entacapone helps slow the breakdown of Levodopa in the body, allowing it to remain effective for a longer period and improving symptom control between doses.

3. What do the strengths 12.5mg-50mg-200mg represent?

Each tablet contains Carbidopa 12.5mg, Levodopa 50mg, and Entacapone 200mg. These ingredients work together to improve dopamine availability and enhance treatment effectiveness.

4. Is urine discoloration normal while taking this medication?

Yes. Entacapone may cause a harmless brownish-orange discoloration of urine, sweat, or saliva. This effect is expected and generally does not require medical attention.

5. Can Carbidopa-Levodopa-Entacapone 50 cure Parkinson’s disease?

No. This medication does not cure Parkinson’s disease. However, it can help manage symptoms, improve movement control, and enhance quality of life when used as prescribed.

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Carbidopa-Levodopa-Entacapone 50 should be used only under the supervision of a qualified healthcare provider.